Delivery Order SPE2DB22D3501-SPE2DB25FVN74
Award Date
5/5/25
Potential Completion Date
5/6/25
Potential Value
$5.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Gralise ER 600 mg tablets. The contract has a ceiling value of $1,029.03 and a period of performance through April 4, 2025. The contract is a firm-fixed price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,189.30, is a firm fixed-price delivery order for the provision of 4564931397 GRALISE ER 300 MG TABLET 90S. The contract has an ultimate completion date of June 18, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,519.89, is for the supply of Gralise ER 600 mg tablets. The contract has a firm fixed price and an ultimate completion date of February 7, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,213.96 contract is for the supply of GRALISE ER 600 MG TABLET 90S, a prescription medication, with a completion date of November 16, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Gralise ER 300 mg tablets, a medication used for the treatment of neuropathic pain. The contract has a ceiling value of $37,507.84 and a completion date of December 13, 2023. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $3,802.81, is for the delivery of GRALISE ER 300 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of April 9, 2025 and is a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,870.52, is for the delivery of Gralise ER 300 mg tablets. The award has an ultimate completion date of May 24, 2023 and is a Firm Fixed Price Delivery Order contract. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora,...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical for the supply of Gralise ER 600 mg tablets. The contract has a ceiling value of $5,616.54 and an ultimate completion date of September 13, 2024. This contract is not set aside for any specific business type. Amerisourcebergen holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical and the Department...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division for the supply of GRALISE ER 300 mg tablets. The $2,861.65 firm-fixed-price contract has an ultimate completion date of August 29, 2024. AmerisourceBergen, a major pharmaceutical distributor, is providing these prescription medications to support military treatment facilities and federal healthcare programs. This award is part of a larger Indefinite Delivery...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract has a ceiling value of $2,630.61 and is for the delivery of the pharmaceutical product Gralise ER 300 mg Tablet 90s. Amerisourcebergen Drug Corp, as the prime contractor, is responsible for providing this medication and other pharmaceutical and medical supplies to support military...